| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $4,166,155 ) |
| | 2025 | 2025 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | P20GM139762 | Translational Hearing Center | 001 | 5 | NIH | 6/11/2025 | $2,160,551 |
| | 2025 | 2025 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R21AI185362 | Role of a RAG1-DCAF1(VprBP)-Ezh2 axis in B cell development | 000 | 2 | NIH | 4/21/2025 | $183,750 |
| | 2025 | 2025 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01AG077574 | Regulatory Mechanisms Governing BubR1 Protein Stability During Stress and Aging | 001 | 4 | NIH | 6/18/2025 | $23,862 |
| | 2025 | 2025 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01AG077574 | Regulatory Mechanisms Governing BubR1 Protein Stability During Stress and Aging | 000 | 4 | NIH | 3/25/2025 | $268,448 |
| | 2025 | 2025 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01NS126418 | Autoresuscitation and SUDEP | 000 | 4 | NIH | 2/14/2025 | $323,474 |
| | 2025 | 2025 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R21DC020983 | Understanding the role of stress hormones in Meniere's disease | 000 | 2 | NIH | 5/2/2025 | $183,750 |
| | 2025 | 2025 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01DC021954 | Natural-based therapies for sensory disorders | 000 | 1 | NIH | 4/15/2025 | $581,105 |
| | 2025 | 2025 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R00DC020759 | Subthreshold vestibular stimulation as a strategy for rehabilitation | 001 | 3 | NIH | 4/29/2025 | $24,900 |
| | 2025 | 2025 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R00DC020759 | Subthreshold vestibular stimulation as a strategy for rehabilitation | 000 | 3 | NIH | 12/19/2024 | $224,100 |
| | 2025 | 2025 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R21AI180688 | Heteromers and L-type calcium channels: Increasing the potency of emodepside in filarial nematode model, Brugia malayi | 000 | 1 | NIH | 11/15/2024 | $226,738 |
| | 2025 | 2025 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01MH133600 | Epigenetic regulation of the neuroendocrine axis in brain development and behavior | 000 | 1 | NIH | 11/13/2024 | $439,804 |
| | 2025 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01DC020701 | Determining the ototoxic potential of COVID-19 therapeutics using machine learning and in vivo approaches | 005 | 3 | NIH | 5/5/2025 | $34 |
| | 2025 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01DC020701 | Determining the ototoxic potential of COVID-19 therapeutics using machine learning and in vivo approaches | 002 | 3 | NIH | 3/19/2025 | $255,266 |
| | 2025 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01DC018850 | Repurposing an FDA approved Drug, B-Raf Kinase Inhibitor Dabrafenib for Protection from Cisplatin- and Noise- induced Hearing Loss | 002 | 4 | NIH | 12/17/2024 | -$1 |
| | 2025 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R25DC021132 | Enhancing Diverse Graduate Student Opportunities in Auditory and Vestibular Neuroscience | 000 | 1 | NIH | 5/22/2025 | $0 |
| | 2025 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01DC021070 | Identification and characterization of novel functions for the Usher proteins in the inner ear | 000 | 2 | NIH | 5/23/2025 | $0 |
| | 2025 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R00ES033259 | The Role of Aquaporin 3 in Arsenic-Induced DNA Damage and Mutagenesis | 002 | 4 | NIH | 4/30/2025 | -$1,588 |
| | 2025 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R00ES033259 | The Role of Aquaporin 3 in Arsenic-Induced DNA Damage and Mutagenesis | 000 | 4 | NIH | 1/22/2025 | -$176,635 |
| | 2025 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | P20GM139762 | Translational Hearing Center | 000 | 4 | NIH | 11/21/2024 | $0 |
| | 2025 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | K01DC018852 | Development of Afferent and Efferent Innervation in the Inner Ear | 005 | 6 | NIH | 6/16/2025 | $0 |
| | 2025 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | K01DC018852 | Development of Afferent and Efferent Innervation in the Inner Ear | 002 | 6 | NIH | 3/18/2025 | $0 |
| | 2025 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | K01DC018852 | Development of Afferent and Efferent Innervation in the Inner Ear | 001 | 6 | NIH | 10/16/2024 | $115,601 |
| | 2025 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01DC020701 | Determining the ototoxic potential of COVID-19 therapeutics using machine learning and in vivo approaches | 005 | 3 | NIH | 5/5/2025 | $16 |
| | 2025 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R21NS132590 | Structure-Function and Signaling of Glutamate Delta 1 in Pain Mechanism | 000 | 1 | NIH | 2/21/2025 | -$1 |
| | 2025 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01DC018850 | Repurposing an FDA approved Drug, B-Raf Kinase Inhibitor Dabrafenib for Protection from Cisplatin- and Noise- induced Hearing Loss | 001 | 3 | NIH | 12/17/2024 | -$402,857 |
| | 2025 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01NS118731 | Trans-synaptic signaling complex in amygdala pain mechanisms | 001 | 4 | NIH | 12/4/2024 | -$137,354 |
| | 2025 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01DC016680 | Clinical factors in aminoglycoside-induced ototoxicity | 000 | 5 | NIH | 10/16/2024 | $0 |
| | 2025 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | F30DC019528 | Repurposing momelotinib for the prevention of aminoglycoside-induced ototoxicity | 000 | 3 | NIH | 11/27/2024 | -$25,619 |
| | 2025 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | E1119074 | HPSL - Dentistry | 001 | 3 | HRSA | 10/18/2024 | $0 |
| | 2025 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | E4C24385 | NSL - Baccalaureate Nursing | 001 | 2 | HRSA | 10/1/2024 | $0 |
| | 2025 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R15EY032275 | Novel ocular hypotensive and neuroprotective microparticle-based hydrogen sulfide delivery system | 000 | 1 | NIH | 2/21/2025 | $0 |
| | 2025 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01DC018850 | Repurposing an FDA approved Drug, B-Raf Kinase Inhibitor Dabrafenib for Protection from Cisplatin- and Noise- induced Hearing Loss | 000 | 2 | NIH | 12/17/2024 | -$28,785 |
| | 2025 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R21AI153688 | Role of RACK1 in RAG1 degradation and B cell development | 000 | 2 | NIH | 1/14/2025 | $0 |
| | 2025 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01NS118731 | Trans-synaptic signaling complex in amygdala pain mechanisms | 000 | 3 | NIH | 12/4/2024 | -$35,823 |
| | 2025 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01NS103763 | Mechanisms of prion strain dynamics | 000 | 5 | NIH | 11/12/2024 | -$16,914 |
| | 2025 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R21AI159127 | A novel form of light chain gene replacement | 000 | 2 | NIH | 4/22/2025 | -$10,283 |
| | 2025 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | D1832118 | Health Careers Opportunity Program | 03 | 5 | HRSA | 2/28/2025 | -$9,383 |
|
| Issue Date FY: 2024 ( Subtotal = $8,329,441 ) (Continued on the next page) |
| | 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01NS133050 | Contributions of prion strains and substrains to prion zoonotic potential and evolution | 000 | 2 | NIH | 6/14/2024 | $527,952 |
| | 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01DC021070 | Identification and characterization of novel functions for the Usher proteins in the inner ear | 000 | 2 | NIH | 5/9/2024 | $491,052 |
| | 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01NS126418 | Autoresuscitation and SUDEP | 001 | 3 | NIH | 5/6/2024 | $25,106 |
| | 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01NS126418 | Autoresuscitation and SUDEP | 000 | 3 | NIH | 1/10/2024 | $322,790 |
| | 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01HL164593 | A Novel Approach to Target Neutrophilic Airway Inflammation and Airway Hyperresponsiveness in Therapy-Resistant (Refractory) Asthma. | 000 | 2 | NIH | 6/17/2024 | $79,893 |
| | 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01HL164593 | A Novel Approach to Target Neutrophilic Airway Inflammation and Airway Hyperresponsiveness in Therapy-Resistant (Refractory) Asthma. | 000 | 2 | NIH | 6/17/2024 | $343,000 |
| | 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01CA253573 | Targeting aberrant anti-apoptotic signaling for prevention of skin cancer | 000 | 5 | NIH | 4/9/2024 | $316,190 |
| | 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | P20GM139762 | Translational Hearing Center | 001 | 4 | NIH | 3/27/2024 | $1,957,592 |
| | 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R00DC020759 | Subthreshold vestibular stimulation as a strategy for rehabilitation | 001 | 2 | NIH | 5/13/2024 | $9,243 |
| | 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R00DC020759 | Subthreshold vestibular stimulation as a strategy for rehabilitation | 000 | 2 | NIH | 1/29/2024 | $248,711 |
| | 2024 | 2024 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R00ES033259 | The Role of Aquaporin 3 in Arsenic-Induced DNA Damage and Mutagenesis | 000 | 4 | NIH | 7/31/2024 | $236,245 |
|
